Exchange: NASDAQ·Updated 06:34 PM EDT
ALHC logo

ALHC Alignment Healthcare Inc

$8.15
$0.12
(1.45%)
Today
Closed $8.40
$0.2493
(2.97%)
After Hours
EarningsOct 29
Mkt Cap$1.72B
Vol3.59M

About ALHC

Alignment Healthcare, Inc. is a holding company, which offers a consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. It offers health plan options through Alignment Health Plan, and partners with select health plans to help deliver better benefits at lower costs. The company was founded by John E. Kao in 2013 and is headquartered in Orange, CA.
36

Bearish Sentiment

How do you feel about ALHC?

DJtheDegen
$ALHC $CLOV why does it always pump pre-market, rise in the morning .... then fall thru rest of the day??? garbage is as garbage does ..... seems its next to impossible to make a few bucks with small caps in pedo's rigged market ..... unless you buy Big Oil and AI like him .... 21000 trades in first 6 months of 2026 ,,,, retarrded MAGAT deserve scum leaders like these to rip them off ........ wheeeee.... //\\
2
7
ChessGM
$ALHC The new 2027 Star Rating affects 2028 payments, not 2026 or 2027. CMS explicitly uses the rating announced in one year to set quality-bonus economics for the subsequent payment year. Centers for Medicare & Medicaid Services That gives Alignment roughly 14–15 months before Jan. 1, 2028 to respond. And it has several possible levers: - improve H3815 itself and challenge/recalculate the rating if appropriate; - launch or expand plans under higher-rated contracts where CMS permits; - encourage voluntary migration during AEP; - redesign 2028 benefits and bids; - adjust provider contracts; - improve coding/risk adjustment; - reduce supplemental benefits to offset lost rebate dollars; - accelerate growth outside H3815.
1
4
YouVSYou
Tampa Bay +9.5 Thurs Night Football YVY After Hours / Top 5 moves from the board $ALHC -21% / Updated Medicare ratings hammered it. Big damage here. $HUM +16% / Largest Medicare contract regained bonus eligibility. Money coming back into the picture. $T -8% / Hit on SpaceX spectrum news. Telecom getting slapped. $CLOV +7.8% / Catching a bid on updated Medicare ratings. $VZ -7% / Same SpaceX headline weighing on it. Let the selling settle before fishing.
7
JRTrader0829
$ALHC $CLOV this guy must be taking estrogen or something… My toddler has more emotional intelligence. Just cries and fantasizes about Trump all day. Sad shit man. Read the room.
7
ChessGM
$ALHC nice discount. I liked it at $15, then $13, then $10, and now even more so. This and next year are fine and by 28 the network will expand and so are the profits.
5
MrLucky123
$ALHC i don't see the kind of call buying I see in November very often. You wanna buy stock here
1
2
SeniorVip
$ALHC 1) The star rating downgrade is an old news that is known since September 14th 2026 when the stock price dropped $13 to $7 2) The downgrade affects year 2028 not year 2027. So the company has plenty of time to contest the rating and or modify the plan to get a higher rating. 3) The downgrade affect 1 plant out of more than 20 plans. so the side effect if any will be limited if the rating hold. 4) The institutional ownership is >120%. They did not dispose their shares after the last drop because they see the potential. Most probably, they will add more after this 20% discount today. 5) the after hours volume is very small compared to the float and it mainly was focused in a q big transaction of $2M shares and the selling did not continue in the after hours nor the night session which indicates no downward pressure and the stock price will likely rebound in the morning It is a huge buing opportunity for me and that is why I am adding here. GLTA
4
MrLucky123
$ALHC tough to put lipstick on a pig. Big vol flush is probably a bottom next few trading days. CMS didn't help
4
TraderByTrade
$ALHC let's be honest. All of the bad news including any potential bad earnings are currently cooked into the price. Any good news should see upside while bad news price neutral.
1
1
capntrps
$ALHC i have bought and traded this falling knife. Not successfully. Hoping the structural concerns are less severe than market is pricing, but looks kinda bleak.
1
1
Tellyourfolkshi
$ALHC their wealth is probably currently being transferring to $CLOV but hey its not too late jump ship.
4
ScrotusMagnum
$ALHC $CLOV there is distince possibility of delisting after a ch. 11 bankruptcy is declared. Conversion is poor, EBITDA is non-existent and the entire healthcare insurance services sector is a scam anyway. Tread carefuilly - trade but do not hold dear. NFA.
3
MrLucky123
$ALHC you know the old saying they don't ring a bell at tops and bottoms? Well 30k call options trading and IV of 114, that's one heck of a bell.
3
DJtheDegen
$ALHC its a deab stpock, end the year below 5 maybe $CLOV another deabt storck, and going to end uner 3 possibly Kow what you own, never exceed speed limits //\\
3
BazingAC
$ALHC 30k calls traded, looks like strategy trades in the Nov expiration Earnings 10/30 Ive added here
3
TraderByTrade
$ALHC I investigated a few different companies with ChatGPT before putting in here. This was his summary write-up for it: Why it dropped / why it could recover Two main hits: 1. A former exec alleged ALHC improperly capitalized ~$8–10M of tech expenses. ALHC disputes it. 2. Management said Q3 hospital and skilled-nursing costs were running hotter than expected, raising fears about margins. But the operating business hasn’t collapsed. Q2: revenue +31.6%, membership +31.5%, adjusted EBITDA +48.4%, net income $36.6M, and medical benefit ratio actually improved YoY. Management also kept 2026 guidance intact despite the cost pressure. The recovery case is simple: if medical costs normalize, guidance holds, and membership keeps growing, the stock may have fallen much further than the fundamentals justified. Main risks: persistent medical-cost inflation, weaker Star Ratings, or the accounting allegations developing into something more serious.
3
heikoscreens
$ALHC follow-up on my Friday post about the star-ratings cut (main California contract 4.0 to 3.5 stars for 2027). It was 7.65 when I posted. Today: 8.13, +7.8% at 11:07 ET, top gainer in the S&P SmallCap 600 on my dashboard. I couldn't find a new headline behind it. For perspective it's still -35% over 1 month and -53% over 1 year, with the 52-week high way up at 25.12. My screener isn't flagging it on anything right now, no momentum buy and no volume surge, so on my data this reads more like a relief bounce than a trend change. The company said it plans to challenge the rating. Is the market starting to price an appeal win, or is this just short covering after a brutal month? No position.
2
spacsaholic
$ALHC We intend to pursue all available administrative remedies and to litigate the measures and methodologies we believe warrant review. At the same time, our strategy remains unchanged, and we remain confident in our ability to deliver exceptional care and return our California HMO contract to at least a 4-Star Rating."
2
DJtheDegen
$ALHC $CLOV down every single day ffs ... red, read, red!!! all goin straight down to 0.0 ... don't be a hero!!! .... ALHC wait till it eaches 5 or lower, most likely by Dec first week .... CLOV stuck in range, due to lousy financials and inability to generate high EBITDA ...... ugghhh!!! //\\
2
KryptonResearch14
$ALHC Friday's tape on the star cut was ugly: opened down about 20 percent, closed near 7.55, down about 13 percent. The street moved the same day. BofA (Kevin Fischbeck) cut to Neutral from Buy and took the target to 9 from 25, noting Alignment went from 100 percent of members in 4-star-plus plans to 25 percent. William Blair downgraded to Market Perform. JPMorgan kept its Overweight but cut the target to 10 from 22. The legal overhang is not helping: a federal judge refused to toss the whistleblower suit from Alignment's former CTO, who alleges 8 to 10 million dollars of operating expenses were booked as capex to inflate adjusted EBITDA. The ruling was procedural, not on the merits, and the company calls the claims wholly without merit. BofA's one offset: if the H3815 rating recovers, 2029 gets a meaningful profitability lift.
1

Advertisement|Remove ads.